{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:36:17Z","timestamp":1773916577411,"version":"3.50.1"},"reference-count":44,"publisher":"American Association for Cancer Research (AACR)","issue":"18","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Purpose: Successful therapy of patients with prostate cancer is highly dependent on reliable diagnostic and prognostic biomarkers. Brachyury is considered a negative prognostic factor in colon and lung cancer; however, there are no reports on Brachyury's expression in prostate cancer.<\/jats:p>\n                  <jats:p>Experimental Design: In this study, we aimed to assess the impact of Brachyury expression in prostate tumorigenesis using a large series of human prostate samples comprising benign tissue, prostate intraepithelial neoplasia (PIN) lesions, localized tumor, and metastatic tissues. The results obtained were compared with what can be inferred from the Oncomine database. In addition, multiple in vitro models of prostate cancer were used to dissect the biologic role of Brachyury in prostate cancer progression.<\/jats:p>\n                  <jats:p>Results: We found that Brachyury is significantly overexpressed in prostate cancer and metastatic tumors when compared with normal tissues, both at protein and at mRNA levels. Brachyury expression in the cytoplasm correlates with highly aggressive tumors, whereas the presence of Brachyury in the nucleus is correlated with tumor invasion. We found that Brachyury-positive cells present higher viability, proliferation, migration, and invasion rates than Brachyury-negative cells. Microarray analysis further showed that genes co-expressed with Brachyury are clustered in oncogenic-related pathways, namely cell motility, cell-cycle regulation, and cell metabolism.<\/jats:p>\n                  <jats:p>Conclusions: Collectively, the present study suggests that Brachyury plays an important role in prostate cancer aggressiveness and points, for the first time, to Brachyury as a significant predictor of poor prostate cancer prognosis. Our work paves the way for future studies assessing Brachyury as a possible prostate cancer therapeutic target. Clin Cancer Res; 20(18); 4949\u201361. \u00a92014 AACR.<\/jats:p>","DOI":"10.1158\/1078-0432.ccr-14-0421","type":"journal-article","created":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T00:43:01Z","timestamp":1404952981000},"page":"4949-4961","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["T-box Transcription Factor Brachyury Is Associated with Prostate Cancer Progression and Aggressiveness"],"prefix":"10.1158","volume":"20","author":[{"given":"Filipe","family":"Pinto","sequence":"first","affiliation":[{"name":"1Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal."},{"name":"2ICVS\/3B's \u2013 PT Government Associate Laboratory, Braga\/Guimar\u00e3es, Portugal."}]},{"given":"Nelma","family":"P\u00e9rtega-Gomes","sequence":"additional","affiliation":[{"name":"1Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal."},{"name":"2ICVS\/3B's \u2013 PT Government Associate Laboratory, Braga\/Guimar\u00e3es, Portugal."}]},{"given":"M\u00e1rcia S.","family":"Pereira","sequence":"additional","affiliation":[{"name":"1Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal."},{"name":"2ICVS\/3B's \u2013 PT Government Associate Laboratory, Braga\/Guimar\u00e3es, Portugal."}]},{"given":"Jos\u00e9 R.","family":"Vizca\u00edno","sequence":"additional","affiliation":[{"name":"3Department of Pathology, Centro Hospitalar do Porto, Portugal."}]},{"given":"Pedro","family":"Monteiro","sequence":"additional","affiliation":[{"name":"4Centro Hospitalar do Alto Ave-Guimar\u00e3es, Portugal."}]},{"given":"Rui M.","family":"Henrique","sequence":"additional","affiliation":[{"name":"5Cancer Epigenetics Group \u2013 Research Center, Portuguese Oncology Institute-Porto, Porto, Portugal."},{"name":"6Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences, University of Porto, Porto, Portugal."},{"name":"7Department of Pathology, Portuguese Oncology Institute - Porto, Porto, Portugal."}]},{"given":"F\u00e1tima","family":"Baltazar","sequence":"additional","affiliation":[{"name":"1Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal."},{"name":"2ICVS\/3B's \u2013 PT Government Associate Laboratory, Braga\/Guimar\u00e3es, Portugal."}]},{"given":"Raquel P.","family":"Andrade","sequence":"additional","affiliation":[{"name":"1Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal."},{"name":"2ICVS\/3B's \u2013 PT Government Associate Laboratory, Braga\/Guimar\u00e3es, Portugal."}]},{"given":"Rui M.","family":"Reis","sequence":"additional","affiliation":[{"name":"1Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal."},{"name":"2ICVS\/3B's \u2013 PT Government Associate Laboratory, Braga\/Guimar\u00e3es, Portugal."},{"name":"8Molecular Oncology Research Center, Barretos Cancer Hospital, S. Paulo, Brazil."}]}],"member":"1086","published-online":{"date-parts":[[2014,9,14]]},"reference":[{"key":"2022061020572365500_bib1","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1016\/j.ejca.2010.09.013","article-title":"Prostate cancer incidence and mortality trends in 37 European countries: an overview","volume":"46","author":"Bray","year":"2010","journal-title":"Eur J Cancer"},{"key":"2022061020572365500_bib2","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J Clin Invest"},{"key":"2022061020572365500_bib3","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.devcel.2008.05.009","article-title":"Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis","volume":"14","author":"Yang","year":"2008","journal-title":"Dev Cell"},{"key":"2022061020572365500_bib4","first-page":"531","article-title":"Origin and evolution of endoderm and mesoderm","volume":"47","author":"Technau","year":"2003","journal-title":"Int J Dev Biol"},{"key":"2022061020572365500_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/path.1969","article-title":"Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas","volume":"209","author":"Vujovic","year":"2006","journal-title":"J Pathol"},{"key":"2022061020572365500_bib6","doi-asserted-by":"crossref","first-page":"S509","DOI":"10.1245\/s10434-013-2914-9","article-title":"Expression of brachyury gene is a significant prognostic factor for primary lung carcinoma","volume":"20","author":"Haro","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"2022061020572365500_bib7","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.3892\/ijo.2012.1673","article-title":"T-box transcription factor Brachyury expression is correlated with epithelial-mesenchymal transition and lymph node metastasis in oral squamous cell carcinoma","volume":"41","author":"Imajyo","year":"2012","journal-title":"Int J Oncol"},{"key":"2022061020572365500_bib8","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ejca.2010.11.015","article-title":"Brachyury expression predicts poor prognosis at early stages of colorectal cancer","volume":"47","author":"Kilic","year":"2011","journal-title":"Eur J Cancer"},{"key":"2022061020572365500_bib9","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1158\/1078-0432.CCR-11-3211","article-title":"Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer","volume":"18","author":"Roselli","year":"2012","journal-title":"Clin Cancer Res"},{"key":"2022061020572365500_bib10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/ijc.26029","article-title":"BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells","volume":"130","author":"Sarkar","year":"2012","journal-title":"Int J Cancer"},{"key":"2022061020572365500_bib11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/1471-2407-12-377","article-title":"The T-box transcription factor Brachyury regulates epithelial-mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells","volume":"12","author":"Shimoda","year":"2012","journal-title":"BMC Cancer"},{"key":"2022061020572365500_bib12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1172\/JCI38379","article-title":"The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells","volume":"120","author":"Fernando","year":"2010","journal-title":"J Clin Invest"},{"key":"2022061020572365500_bib13","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1158\/1535-7163.MCT-12-1007","article-title":"An autocrine loop between TGF-beta1 and the transcription factor brachyury controls the transition of human carcinoma cells into a mesenchymal phenotype","volume":"12","author":"Larocca","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"2022061020572365500_bib14","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1158\/0008-5472.CAN-11-0156","article-title":"IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells","volume":"71","author":"Fernando","year":"2011","journal-title":"Cancer Res"},{"key":"2022061020572365500_bib15","doi-asserted-by":"crossref","first-page":"e682","DOI":"10.1038\/cddis.2013.208","article-title":"The embryonic transcription factor Brachyury blocks cell cycle progression and mediates tumor resistance to conventional antitumor therapies","volume":"4","author":"Huang","year":"2013","journal-title":"Cell Death Dis"},{"key":"2022061020572365500_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbrc.2007.10.144","article-title":"Epigenetic silencing of human T (brachyury homologue) gene in non-small-cell lung cancer","volume":"365","author":"Park","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"2022061020572365500_bib17","article-title":"AJCC cancer staging manual","author":"Edge","year":"2010","edition":"7th ed"},{"key":"2022061020572365500_bib18","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","article-title":"The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma","volume":"29","author":"Epstein","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"2022061020572365500_bib19","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/pros.22620","article-title":"Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer","volume":"73","author":"P\u00e9rtega-Gomes","year":"2013","journal-title":"Prostate"},{"key":"2022061020572365500_bib20","doi-asserted-by":"crossref","first-page":"e59104","DOI":"10.1371\/journal.pone.0059104","article-title":"RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapy","volume":"8","author":"Martinho","year":"2013","journal-title":"PLoS One"},{"key":"2022061020572365500_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/hmg\/dds405","article-title":"Loss of WNK2 expression by promoter gene methylation occurs in adult gliomas and triggers Rac1-mediated tumour cell invasiveness","volume":"22","author":"Moniz","year":"2013","journal-title":"Hum Mol Genet"},{"key":"2022061020572365500_bib22","first-page":"4499","article-title":"Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease","volume":"62","author":"LaTulippe","year":"2002","journal-title":"Cancer Res"},{"key":"2022061020572365500_bib23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ccr.2005.10.001","article-title":"Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression","volume":"8","author":"Varambally","year":"2005","journal-title":"Cancer Cell"},{"key":"2022061020572365500_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature11125","article-title":"The mutational landscape of lethal castration-resistant prostate cancer","volume":"487","author":"Grasso","year":"2012","journal-title":"Nature"},{"key":"2022061020572365500_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"key":"2022061020572365500_bib26","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1172\/JCI20032","article-title":"Gene expression profiling predicts clinical outcome of prostate cancer","volume":"113","author":"Glinsky","year":"2004","journal-title":"J Clin Invest"},{"key":"2022061020572365500_bib27","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1200\/JCO.2004.05.158","article-title":"Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy","volume":"22","author":"Yu","year":"2004","journal-title":"J Clin Oncol"},{"key":"2022061020572365500_bib28","author":"The Cancer Genome Atlas (TCGA)"},{"key":"2022061020572365500_bib29","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1158\/1078-0432.CCR-09-0911","article-title":"Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer","volume":"15","author":"Arredouani","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2022061020572365500_bib30","author":"Oncomine"},{"key":"2022061020572365500_bib31","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1593\/neo.07112","article-title":"Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles","volume":"9","author":"Rhodes","year":"2007","journal-title":"Neoplasia"},{"key":"2022061020572365500_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat Protoc"},{"key":"2022061020572365500_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Huang da","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"2022061020572365500_bib34","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/343657a0","article-title":"Expression pattern of the mouse T gene and its role in mesoderm formation","volume":"343","author":"Wilkinson","year":"1990","journal-title":"Nature"},{"key":"2022061020572365500_bib35","doi-asserted-by":"crossref","first-page":"e875","DOI":"10.1038\/cddis.2013.407","article-title":"Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K\/Akt\/mTOR pathway in prostate cancer radioresistance","volume":"4","author":"Chang","year":"2013","journal-title":"Cell Death Dis"},{"key":"2022061020572365500_bib36","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1158\/1078-0432.CCR-06-2353","article-title":"The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cell-mediated cancer immunotherapy","volume":"13","author":"Palena","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2022061020572365500_bib37","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.18632\/oncotarget.1295","article-title":"Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine","volume":"4","author":"Hamilton","year":"2013","journal-title":"Oncotarget"},{"key":"2022061020572365500_bib38","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nrc3603","article-title":"The roles of TGFbeta in the tumour microenvironment","volume":"13","author":"Pickup","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"2022061020572365500_bib39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12307-011-0073-8","article-title":"The PCa tumor microenvironment","volume":"4","author":"Sottnik","year":"2011","journal-title":"Cancer Microenviron"},{"key":"2022061020572365500_bib40","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1158\/1535-7163.MCT-12-0895","article-title":"Endothelial cells enhance prostate cancer metastasis via IL-6\u2013&gt;androgen receptor\u2013&gt;TGF-beta\u2013&gt;MMP-9 signals","volume":"12","author":"Wang","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"2022061020572365500_bib41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/path.2816","article-title":"Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study","volume":"223","author":"Presneau","year":"2011","journal-title":"J Pathol"},{"key":"2022061020572365500_bib42","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"2022061020572365500_bib43","doi-asserted-by":"crossref","first-page":"e40716","DOI":"10.1371\/journal.pone.0040716","article-title":"In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147","volume":"7","author":"Hao","year":"2012","journal-title":"PLoS One"},{"key":"2022061020572365500_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10585-011-9423-7","article-title":"CD44 is a biomarker associated with human prostate cancer radiation sensitivity","volume":"29","author":"Xiao","year":"2012","journal-title":"Clin Exp Metastasis"}],"container-title":["Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/20\/18\/4949\/2021244\/4949.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/20\/18\/4949\/2021244\/4949.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T21:49:00Z","timestamp":1654897740000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article\/20\/18\/4949\/13338\/T-box-Transcription-Factor-Brachyury-Is-Associated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,14]]},"references-count":44,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2014,9,14]]},"published-print":{"date-parts":[[2014,9,15]]}},"URL":"https:\/\/doi.org\/10.1158\/1078-0432.ccr-14-0421","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1078-0432.22454382.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22454397","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22454376","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22454388","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22454376.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22454379","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22454373.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22454379.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.c.6522738.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22454394.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22454388.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.c.6522738","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22454397.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22454391","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22454391.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22454382","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22454394","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22454373","asserted-by":"object"}]},"ISSN":["1078-0432","1557-3265"],"issn-type":[{"value":"1078-0432","type":"print"},{"value":"1557-3265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,14]]}}}